---
title: "LIMAD"
description: "Mapping microbe-derived amyloids and their interactions with AÎ²42 and Î±-synuclein to illuminate new avenues against Alzheimerâ€™s and Parkinsonâ€™s"
editor: 
  markdown: 
    wrap: sentence
---

## ğŸ§  Importance of human microbiome in neurodegenerative diseases

**LIMAD: Large-scale identification of microorganism products impacting amyloid diseases**

**PI**: Valen  
**Funding agency**: National Science Center Poland  
**Programme**: Miniatura 9  
**Grant ID**: 2025/09/X/NZ7/00600  
**Start date**:  21 Aug 2025  
**Duration**: 12 months  
**Budget**: PLN49,999.00   


Protein aggregation and amyloid deposits are hallmarks of neurodegenerative diseases such as **Alzheimerâ€™s (AD)** and **Parkinsonâ€™s (PD)**. Emerging evidence suggests that **microbial proteins** can influence the misfolding of human amyloidogenic proteins (notably **AÎ²42** and **Î±-synuclein**), potentially via the gutâ€“brain axis. **LIMAD** aims to systematically uncover microbial proteins with amyloid potential and evaluate their ability to **interact with and promote aggregation** of AÎ²42 and Î±-synuclein.


### ğŸ“Œ Project highlights
- ğŸ” Systematic review of microbes linked to Alzheimerâ€™s & Parkinsonâ€™s  
- ğŸ§¬ Screening microbial proteins for amyloid potential  
- ğŸ¤– Using ML & structural biology to test cross-interactions with AÎ²42 & Î±-synuclein  
- ğŸ§ª Generating new hypotheses for microbial contributions to neurodegeneration  
- ğŸ¯ Identifying potential **drug targets** and prevention strategies  


